#1 Clinical Trials Search in Europe

Gabapentin

Gabapentin, a medication originally developed to treat epilepsy, has been the subject of numerous clinical trials exploring its potential benefits for various conditions. This article examines recent studies investigating the use of gabapentin and its extended-release formulations in treating restless legs syndrome (RLS), chronic pain, and alcohol use disorder. We’ll look at the efficacy, safety, and potential applications of gabapentin across different patient populations.

Table of Contents

What is Gabapentin?

Gabapentin is a medication that belongs to a class of drugs called anticonvulsants or antiepileptics. It is also known by brand names such as Neurontin, Gralise, and Horizant[3][4]. Gabapentin was originally developed to treat epilepsy, but over time, its use has expanded to include the treatment of various types of pain and other conditions[1].

What Conditions Does Gabapentin Treat?

Gabapentin is used to treat several conditions, including:

  • Epilepsy: It helps control seizures in people with epilepsy[1].
  • Neuropathic pain: This includes pain caused by nerve damage, such as diabetic neuropathy or post-herpetic neuralgia (pain after shingles)[1].
  • Restless Legs Syndrome (RLS): It can help relieve the uncomfortable sensations associated with RLS[4].
  • Chronic pain conditions: These may include fibromyalgia, chronic pelvic pain, and post-amputation pain[3][5].
  • Postoperative pain: It may be used to reduce pain after surgery[2].

How Does Gabapentin Work?

Gabapentin works by affecting the way nerves send messages to the brain. It is believed to reduce the release of certain neurotransmitters (chemical messengers) in the brain, which helps to calm overactive nerve signals. This action can help reduce seizures, alleviate pain, and improve other symptoms associated with various conditions[1].

Dosage and Administration

The dosage of gabapentin can vary depending on the condition being treated and the individual patient. It is typically taken orally in the form of tablets or capsules. Some important points about dosing include:

  • Gabapentin is often started at a low dose and gradually increased over time to reach an effective dose[3].
  • For some conditions, it may be taken once daily (e.g., Gralise for post-herpetic neuralgia), while for others, it may be taken multiple times a day[3].
  • Extended-release forms of gabapentin (like Horizant) are designed to be taken once daily, usually in the evening[4].
  • It’s important to take gabapentin exactly as prescribed by your doctor and not to stop taking it suddenly without medical advice.

Potential Side Effects

Like all medications, gabapentin can cause side effects. Common side effects may include:

  • Dizziness
  • Drowsiness
  • Fatigue
  • Difficulty with coordination
  • Nausea
  • Blurred vision

These side effects are often mild and may decrease over time. However, if they persist or worsen, it’s important to consult your healthcare provider[6].

Special Considerations

There are some important considerations when taking gabapentin:

  • Driving and operating machinery: Gabapentin can cause drowsiness and affect coordination. Patients are often advised not to drive or operate complex machinery for at least 30 hours after taking a dose, especially when first starting the medication[7].
  • Pregnancy and breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of gabapentin with your doctor.
  • Interactions: Gabapentin can interact with other medications, so it’s important to inform your doctor about all medications you’re taking, including over-the-counter drugs and supplements.

Ongoing Research

Researchers continue to study gabapentin for various uses. Some areas of ongoing research include:

  • Its effectiveness in reducing postoperative pain and opioid consumption after orthopedic surgery in children[2].
  • Its potential to reduce the pressor response (increase in blood pressure) during intubation for surgery[8].
  • Its use in treating chronic pelvic pain associated with conditions like irritable bowel syndrome and interstitial cystitis[3].
  • Its effectiveness in treating phantom limb pain in patients who have undergone amputation[5].

These ongoing studies may lead to new approved uses for gabapentin in the future, potentially benefiting more patients with various conditions.

Aspect Details
Conditions Studied Restless Legs Syndrome (RLS), Chronic Pelvic Pain, Post-Amputation Pain, Alcohol Use Disorder
Formulations Immediate-release gabapentin (Neurontin), Extended-release gabapentin enacarbil (Horizant), Gastroretentive formulation (Gralise)
Patient Populations Adults, Adolescents (13-17 years old)
Key Outcome Measures IRLS Rating Scale, CGI-I Score, Pain Intensity Scales, Alcohol Consumption Patterns
Safety Considerations Adverse events monitoring, focus on neuropsychiatric effects in some trials
Dosing Ranges 300 mg to 1800 mg daily, depending on formulation and condition
Study Durations 12 weeks to 48 weeks, including long-term extension studies

FAQ

  • What conditions are being studied for gabapentin treatment? Recent clinical trials have explored gabapentin's potential in treating restless legs syndrome (RLS), chronic pelvic pain, post-amputation pain, and alcohol use disorder.
  • Are there different formulations of gabapentin being studied? Yes, studies have looked at immediate-release gabapentin (Neurontin), extended-release gabapentin enacarbil (Horizant), and a gastroretentive formulation (Gralise).
  • Is gabapentin being studied in adolescents? Yes, several trials are investigating the use of gabapentin enacarbil (Horizant) in adolescents aged 13-17 with moderate-to-severe primary restless legs syndrome.
  • What are some potential benefits of gabapentin for RLS? Studies suggest gabapentin may help reduce RLS symptoms, improve sleep quality, and potentially address augmentation issues in patients previously treated with dopaminergic agents.
  • Are there any ongoing long-term studies on gabapentin use? Yes, there is an open-label extension study evaluating the long-term efficacy and safety of Horizant in adolescents with RLS for up to 48 weeks of treatment.

Ongoing Clinical Trials on Gabapentin

  • Study on Gabapentin for Treating Nerve Pain in the Leg from Lower Back Pain

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness and Safety of DFL24412 and Ketoprofen Lysine in Patients with Chronic Low Back Pain

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy Spain

  • Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

  • Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

  • Study on Gabapentin and Placebo for Short-Term Relief of Acute Lower Back Pain from Herniated Disc in Adults

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Augmentation: A worsening of restless legs syndrome symptoms that can occur as a complication of long-term treatment with certain medications, particularly dopaminergic agents.
  • Gabapentin enacarbil: An extended-release prodrug formulation of gabapentin, marketed under the brand name Horizant, designed to provide more consistent drug levels throughout the day.
  • Restless Legs Syndrome (RLS): A neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations, typically occurring in the evening or at night.
  • International Restless Legs Syndrome Rating Scale (IRLS): A standardized scale used to assess the severity of RLS symptoms, consisting of 10 questions scored from 0 to 4, with higher scores indicating more severe symptoms.
  • Clinical Global Impression of Improvement (CGI-I): A scale used by healthcare providers to evaluate a patient's response to treatment, ranging from 1 (very much improved) to 7 (very much worse).
  • Pharmacokinetics (PK): The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Alcohol Use Disorder (AUD): A medical condition characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences.
  • Phantom Limb Pain (PLP): Pain that feels like it's coming from a body part that's no longer there, often experienced by amputees.

References

  1. https://clinicaltrials.gov/study/NCT03708237
  2. https://clinicaltrials.gov/study/NCT03005483
  3. https://clinicaltrials.gov/study/NCT01678911
  4. https://clinicaltrials.gov/study/NCT02642315
  5. https://clinicaltrials.gov/study/NCT01776671
  6. https://clinicaltrials.gov/study/NCT01888497
  7. https://clinicaltrials.gov/study/NCT02633657
  8. https://clinicaltrials.gov/study/NCT06705101